Young Diane C. 4

4 · Celldex Therapeutics, Inc. · Filed Aug 19, 2022

Form 4

Period: 2022-08-17

SVP, CHIEF MEDICAL OFFICER

Transactions

Exercise/Conversion
Incentive Stock Option
2022-08-17−19,000→ 48,400 total
Exercise: $10.38Exp: 2030-06-18→ Common Stock (19,000 underlying)
Exercise/Conversion
Common Stock
2022-08-17$10.38/sh+19,000$197,220→ 21,115 total
Exercise/Conversion
Common Stock
2022-08-17$2.71/sh+45,000$121,950→ 47,115 total
Exercise/Conversion
Incentive Stock Option
2022-08-17−45,000→ 15,000 total
Exercise: $2.71Exp: 2029-07-08→ Common Stock (45,000 underlying)
Sale
Common Stock
2022-08-17$37.30/sh−19,000$708,715→ 2,115 total

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.30 to $37.35 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
[F2]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
[F3]25% vested on July 8, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Documents

1 file